Long-Term Outcomes in ICU Patients from REMAP-CAP Trial

Exploration of the 180-day outcomes for pandemic patients in the REMAP-CAP trial, covering various treatments such as antivirals, corticosteroids, and anticoagulants, and comparing their effects on in-hospital mortality and organ support free days.